Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Triacana

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Priority Review to Egetis' Emcitate NDA for MCT8 Deficiency
    FDA Priority Review to Egetis' Emcitate NDA for MCT8 Deficiency

    27 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-27/egetis-announces-fda-acceptance-and-priority-review-of-nda-for-emcitate-r-tiratricol-for-mct8-def

    PHARMIWEB
    27 Mar 2026
    Share Share
    Italy bans 7 APIs from compounding pharmacies after off-label abuse
    Italy bans 7 APIs from compounding pharmacies after off-label abuse

    21 Aug 2015

    // Fiona Barry IN-PHARMA TECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/Italy-bans-7-APIs-from-compounding-pharmacies-after-off-label-abuse

    Fiona Barry IN-PHARMA TECHNOLOGIST
    21 Aug 2015
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.